Inhibiting HDAC1 with PCI-24781 or siRNA reduced oral squamous cell carcinoma (OSCC) cell proliferation by affecting proliferating cell nuclear antigen (PCNA) regulation and mRNA stability. Here, PCNA is linked to oral cavity squamous cell carcinoma.